Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Promising immunizations for diseases that affect mostly people in low- and middle-income countries need help getting to market, urge David C. Kaslow and colleagues.
Misleading terminology and arbitrary divisions stymie drug trials and can give false hope about the potential of tailoring drugs to individuals, warns Stephen Senn.
The Haldane principle, born a century ago, has enabled government scientists to speak truth to power without fear of retribution — cherish it, says Ehsan Masood.
Bitcoin and other cryptocurrencies will founder unless they integrate quantum technologies, warn Aleksey K. Fedorov, Evgeniy O. Kiktenko and Alexander I. Lvovsky.
The first large-scale analysis of compliance with open-access rules reveals that up to one-third of articles are not free to read, report Vincent Larivière and Cassidy R. Sugimoto.
Using artificial intelligence to predict outbursts of violence and probe their causes could save lives, argue Weisi Guo, Kristian Gleditsch and Alan Wilson.
Sand-grain-sized computers, self-healing materials and constellations of craft would reboot our reach, explain Igor Levchenko, Michael Keidar and colleagues.
Confusion about mesenchymal stem cells is making it easier for people to sell unproven treatments, warn Douglas Sipp, Pamela G. Robey and Leigh Turner.